Gene profiling and prediction of response to anastrozole neoadjuvant treatment in breast cancer
Ontology highlight
ABSTRACT: Transcriptome of 17 tru-cut biopsies and 13 matched surgical samples from ER+ breast tumor patients, treated for 3 months with Anastrozole were anayzed to identify a robust expression signature predictive of response to Anastrozole neoadjuvant treatment in ER+ breast cancer patients and, at the same time, to delineate treatment effects.
ORGANISM(S): Homo sapiens
PROVIDER: GSE18378 | GEO | 2010/05/17
SECONDARY ACCESSION(S): PRJNA118149
REPOSITORIES: GEO
ACCESS DATA